Phyto	B:C0071011
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
:	O
a	O
systematic	O
review	I:C1955832
and	O
dose	O
-	O
response	O
meta-analysis	O
of	O
observational	O
studies	I:C1518527
.	O

Phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	B:C4229681
cancer	I:C4229681
risk	I:C4229681
:	O
a	O
systematic	O
review	I:C1955832
and	O
dose	O
-	O
response	O
meta-analysis	O
of	O
observational	O
studies	I:C1518527
.	O

Phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
:	O
a	O
systematic	B:C1955832
review	I:C1955832
and	O
dose	O
-	O
response	O
meta-analysis	O
of	O
observational	O
studies	I:C1518527
.	O

Phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
:	O
a	O
systematic	O
review	I:C1955832
and	O
dose	O
-	O
response	O
meta-analysis	B:C0920317
of	O
observational	O
studies	I:C1518527
.	O

Phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
:	O
a	O
systematic	O
review	I:C1955832
and	O
dose	O
-	O
response	O
meta-analysis	O
of	O
observational	B:C1518527
studies	I:C1518527
.	O

Epidemiological	B:C0002783
studies	I:C0002783
suggest	O
that	O
soya	O
consumption	O
as	O
a	O
source	O
of	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
isoflavones	O
may	O
be	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
colorectal	O
cancer	I:C1527249
.	O

Epidemiological	O
studies	I:C0002783
suggest	O
that	O
soya	B:C1258091
consumption	O
as	O
a	O
source	O
of	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
isoflavones	O
may	O
be	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
colorectal	O
cancer	I:C1527249
.	O

Epidemiological	O
studies	I:C0002783
suggest	O
that	O
soya	O
consumption	O
as	O
a	O
source	O
of	O
phyto	B:C0071011
-	I:C0071011
oestrogens	I:C0071011
and	O
isoflavones	O
may	O
be	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
colorectal	O
cancer	I:C1527249
.	O

Epidemiological	O
studies	I:C0002783
suggest	O
that	O
soya	O
consumption	O
as	O
a	O
source	O
of	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
isoflavones	B:C0022179
may	O
be	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
colorectal	O
cancer	I:C1527249
.	O

Epidemiological	O
studies	I:C0002783
suggest	O
that	O
soya	O
consumption	O
as	O
a	O
source	O
of	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
isoflavones	O
may	O
be	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
colorectal	B:C1527249
cancer	I:C1527249
.	O

However	O
,	O
findings	O
have	O
not	O
yet	O
been	O
synthesised	O
for	O
all	O
groups	O
of	O
phyto	B:C0071011
-	I:C0071011
oestrogens	I:C0071011
.	O

A	O
meta-analysis	B:C0920317
was	O
conducted	O
to	O
quantify	O
the	O
association	O
between	O
phyto-	O
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
.	O

A	O
meta-analysis	O
was	O
conducted	O
to	O
quantify	O
the	O
association	O
between	O
phyto-	B:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
.	O

A	O
meta-analysis	O
was	O
conducted	O
to	O
quantify	O
the	O
association	O
between	O
phyto-	O
oestrogens	I:C0071011
and	O
colorectal	B:C4229681
cancer	I:C4229681
risk	I:C4229681
.	O

Relevant	O
observational	B:C1518527
studies	I:C1518527
published	O
up	O
to	O
June	O
2016	O
were	O
identified	O
by	O
searching	O
MEDLINE	O
,	O
EMBASE	O
and	O
Cochrane	O
Library	I:C0282574
databases	I:C0282574
.	O

Relevant	O
observational	O
studies	I:C1518527
published	B:C1704324
up	O
to	O
June	O
2016	O
were	O
identified	O
by	O
searching	O
MEDLINE	O
,	O
EMBASE	O
and	O
Cochrane	O
Library	I:C0282574
databases	I:C0282574
.	O

Relevant	O
observational	O
studies	I:C1518527
published	O
up	O
to	O
June	O
2016	O
were	O
identified	O
by	O
searching	O
MEDLINE	B:C0025141
,	O
EMBASE	O
and	O
Cochrane	O
Library	I:C0282574
databases	I:C0282574
.	O

Relevant	O
observational	O
studies	I:C1518527
published	O
up	O
to	O
June	O
2016	O
were	O
identified	O
by	O
searching	O
MEDLINE	O
,	O
EMBASE	B:C0282574
and	O
Cochrane	O
Library	I:C0282574
databases	I:C0282574
.	O

Relevant	O
observational	O
studies	I:C1518527
published	O
up	O
to	O
June	O
2016	O
were	O
identified	O
by	O
searching	O
MEDLINE	O
,	O
EMBASE	O
and	O
Cochrane	B:C0282574
Library	I:C0282574
databases	I:C0282574
.	O

Study	O
-	O
specific	O
relative	O
risks	O
(	O
RR	O
)	O
were	O
pooled	O
in	O
both	O
categorical	O
and	O
dose	O
-	O
response	O
meta-analyses	B:C0920317
.	O

Out	O
of	O
seventeen	O
identified	B:C2603343
studies	I:C2603343
,	O
sixteen	O
were	O
included	O
in	O
the	O
meta	O
-	I:C0920317
analysis	I:C0920317
.	O

Out	O
of	O
seventeen	O
identified	O
studies	I:C2603343
,	O
sixteen	O
were	O
included	O
in	O
the	O
meta	B:C0920317
-	I:C0920317
analysis	I:C0920317
.	O

Comparing	O
the	O
highest	O
with	O
the	O
lowest	O
intake	O
category	O
,	O
inverse	O
associations	O
for	O
phyto	B:C0071011
-	I:C0071011
oestrogens	I:C0071011
overall	O
and	O
by	O
subgroup	O
were	O
observed	O
but	O
were	O
statistically	O
significant	O
in	O
case	O
-	I:C0007328
controls	I:C0007328
studies	I:C0007328
and	O
not	O
in	O
cohort	O
studies	O
.	O

Comparing	O
the	O
highest	O
with	O
the	O
lowest	O
intake	O
category	O
,	O
inverse	O
associations	O
for	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
overall	O
and	O
by	O
subgroup	B:C1515021
were	O
observed	O
but	O
were	O
statistically	O
significant	O
in	O
case	O
-	I:C0007328
controls	I:C0007328
studies	I:C0007328
and	O
not	O
in	O
cohort	O
studies	O
.	O

Comparing	O
the	O
highest	O
with	O
the	O
lowest	O
intake	O
category	O
,	O
inverse	O
associations	O
for	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
overall	O
and	O
by	O
subgroup	O
were	O
observed	O
but	O
were	O
statistically	O
significant	O
in	O
case	B:C0007328
-	I:C0007328
controls	I:C0007328
studies	I:C0007328
and	O
not	O
in	O
cohort	O
studies	O
.	O

The	O
pooled	O
RR	O
in	O
case	B:C0007328
-	I:C0007328
control	I:C0007328
studies	I:C0007328
were	O
0·76	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·84	O
)	O
,	O
0·77	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·85	O
)	O
and	O
0·70	O
(	O
95	O
%	O
CI	O
0·56	O
,	O
0·89	O
)	O
for	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
,	O
isoflavones	O
and	O
lignans	O
,	O
respectively	O
,	O
whereas	O
the	O
corresponding	O
pooled	O
RR	O
were	O
0·95	O
(	O
95	O
%	O
CI	O
0·85	O
,	O
1·06	O
)	O
,	O
0·94	O
(	O
95	O
%	O
CI	O
0·84	O
,	O
1·05	O
)	O
and	O
1·00	O
(	O
95	O
%	O
CI	O
0·64	O
,	O
1·57	O
)	O
in	O
cohort	O
studies	O
.	O

The	O
pooled	O
RR	O
in	O
case	O
-	I:C0007328
control	I:C0007328
studies	I:C0007328
were	O
0·76	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·84	O
)	O
,	O
0·77	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·85	O
)	O
and	O
0·70	O
(	O
95	O
%	O
CI	O
0·56	O
,	O
0·89	O
)	O
for	O
phyto	B:C0071011
-	I:C0071011
oestrogens	I:C0071011
,	O
isoflavones	O
and	O
lignans	O
,	O
respectively	O
,	O
whereas	O
the	O
corresponding	O
pooled	O
RR	O
were	O
0·95	O
(	O
95	O
%	O
CI	O
0·85	O
,	O
1·06	O
)	O
,	O
0·94	O
(	O
95	O
%	O
CI	O
0·84	O
,	O
1·05	O
)	O
and	O
1·00	O
(	O
95	O
%	O
CI	O
0·64	O
,	O
1·57	O
)	O
in	O
cohort	O
studies	O
.	O

The	O
pooled	O
RR	O
in	O
case	O
-	I:C0007328
control	I:C0007328
studies	I:C0007328
were	O
0·76	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·84	O
)	O
,	O
0·77	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·85	O
)	O
and	O
0·70	O
(	O
95	O
%	O
CI	O
0·56	O
,	O
0·89	O
)	O
for	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
,	O
isoflavones	B:C0022179
and	O
lignans	O
,	O
respectively	O
,	O
whereas	O
the	O
corresponding	O
pooled	O
RR	O
were	O
0·95	O
(	O
95	O
%	O
CI	O
0·85	O
,	O
1·06	O
)	O
,	O
0·94	O
(	O
95	O
%	O
CI	O
0·84	O
,	O
1·05	O
)	O
and	O
1·00	O
(	O
95	O
%	O
CI	O
0·64	O
,	O
1·57	O
)	O
in	O
cohort	O
studies	O
.	O

The	O
pooled	O
RR	O
in	O
case	O
-	I:C0007328
control	I:C0007328
studies	I:C0007328
were	O
0·76	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·84	O
)	O
,	O
0·77	O
(	O
95	O
%	O
CI	O
0·69	O
,	O
0·85	O
)	O
and	O
0·70	O
(	O
95	O
%	O
CI	O
0·56	O
,	O
0·89	O
)	O
for	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
,	O
isoflavones	O
and	O
lignans	B:C0064971
,	O
respectively	O
,	O
whereas	O
the	O
corresponding	O
pooled	O
RR	O
were	O
0·95	O
(	O
95	O
%	O
CI	O
0·85	O
,	O
1·06	O
)	O
,	O
0·94	O
(	O
95	O
%	O
CI	O
0·84	O
,	O
1·05	O
)	O
and	O
1·00	O
(	O
95	O
%	O
CI	O
0·64	O
,	O
1·57	O
)	O
in	O
cohort	O
studies	O
.	O

Dose	O
-	O
response	O
analysis	O
yielded	O
an	O
8	O
%	O
reduced	O
risk	O
of	O
colorectal	B:C0009404
neoplasms	I:C0009404
for	O
every	O
20	O
mg/d	O
increase	O
in	O
isoflavones	O
intake	O
in	O
Asians	O
(	O
pooled	O
RR	O
0·92	O
;	O
95	O
%	O
CI	O
0·86	O
,	O
0·97	O
)	O
.	O

Dose	O
-	O
response	O
analysis	O
yielded	O
an	O
8	O
%	O
reduced	O
risk	O
of	O
colorectal	O
neoplasms	I:C0009404
for	O
every	O
20	O
mg/d	O
increase	O
in	O
isoflavones	B:C0022179
intake	O
in	O
Asians	O
(	O
pooled	O
RR	O
0·92	O
;	O
95	O
%	O
CI	O
0·86	O
,	O
0·97	O
)	O
.	O

Dose	O
-	O
response	O
analysis	O
yielded	O
an	O
8	O
%	O
reduced	O
risk	O
of	O
colorectal	O
neoplasms	I:C0009404
for	O
every	O
20	O
mg/d	O
increase	O
in	O
isoflavones	O
intake	O
in	O
Asians	B:C0078988
(	O
pooled	O
RR	O
0·92	O
;	O
95	O
%	O
CI	O
0·86	O
,	O
0·97	O
)	O
.	O

A	O
non-linear	O
inverse	O
association	O
with	O
colorectal	B:C4229681
cancer	I:C4229681
risk	I:C4229681
was	O
found	O
for	O
lignans	O
intake	O
,	O
but	O
no	O
association	O
for	O
circulating	O
enterolactone	O
concentrations	O
was	O
observed	O
.	O

A	O
non-linear	O
inverse	O
association	O
with	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
was	O
found	O
for	O
lignans	B:C0064971
intake	O
,	O
but	O
no	O
association	O
for	O
circulating	O
enterolactone	O
concentrations	O
was	O
observed	O
.	O

A	O
non-linear	O
inverse	O
association	O
with	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
was	O
found	O
for	O
lignans	O
intake	O
,	O
but	O
no	O
association	O
for	O
circulating	O
enterolactone	B:C0045341
concentrations	O
was	O
observed	O
.	O

Thus	O
,	O
study	B:C2603343
heterogeneity	O
precludes	O
a	O
rigorous	O
conclusion	O
regarding	O
an	O
effect	O
of	O
high	O
exposure	O
to	O
isoflavones	O
on	O
risk	O
of	O
colorectal	O
cancer	I:C1527249
.	O

Thus	O
,	O
study	O
heterogeneity	O
precludes	O
a	O
rigorous	O
conclusion	O
regarding	O
an	O
effect	O
of	O
high	O
exposure	O
to	O
isoflavones	B:C0022179
on	O
risk	O
of	O
colorectal	O
cancer	I:C1527249
.	O

Thus	O
,	O
study	O
heterogeneity	O
precludes	O
a	O
rigorous	O
conclusion	O
regarding	O
an	O
effect	O
of	O
high	O
exposure	O
to	O
isoflavones	O
on	O
risk	O
of	O
colorectal	B:C1527249
cancer	I:C1527249
.	O

Current	O
evidence	O
for	O
an	O
association	O
with	O
lignans	B:C0064971
exposure	O
is	O
limited	O
.	O

Further	O
prospective	B:C0033522
studies	I:C0033522
,	O
particularly	O
evaluating	O
lignans	O
,	O
are	O
warranted	O
to	O
clarify	O
the	O
association	O
between	O
different	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
.	O

Further	O
prospective	O
studies	I:C0033522
,	O
particularly	O
evaluating	O
lignans	B:C0064971
,	O
are	O
warranted	O
to	O
clarify	O
the	O
association	O
between	O
different	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
.	O

Further	O
prospective	O
studies	I:C0033522
,	O
particularly	O
evaluating	O
lignans	O
,	O
are	O
warranted	O
to	O
clarify	O
the	O
association	O
between	O
different	O
phyto	B:C0071011
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	O
cancer	I:C4229681
risk	I:C4229681
.	O

Further	O
prospective	O
studies	I:C0033522
,	O
particularly	O
evaluating	O
lignans	O
,	O
are	O
warranted	O
to	O
clarify	O
the	O
association	O
between	O
different	O
phyto	O
-	I:C0071011
oestrogens	I:C0071011
and	O
colorectal	B:C4229681
cancer	I:C4229681
risk	I:C4229681
.	O

